Pittock; Sean J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pittock; Sean J..The latest application filed is for "autoantibodies as biomarker of paraneoplastic encephalitis associated with testicular cancer".

Company Profile

4.5.17

Pittock; Sean J. - Rochester MN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Autoantibodies As Biomarker Of Paraneoplastic Encephalitis Associated With Testicular Cancer App 20220196662 - DeRisi; Joseph L. ; et al.	2022-06-23
Materials And Methods For Evaluating And Treating Neuromyelitis Optica (nmo) App 20220196652 - Lennon; Vanda A. ; et al.	2022-06-23
Assessing And Treating Germ Cell Tumors And Paraneoplastic Autoimmunity App 20220120744 - Lennon; Vanda A. ; et al.	2022-04-21
Assessing And Treating Autoimmune Ataxia App 20210311047 - HONORAT; Josephe A. ; et al.	2021-10-07
Materials and methods for evaluating and treating cancer Grant 11,061,027 - Pittock , et al. July 13, 2	2021-07-13
Materials And Methods For Evaluating And Treating Neuromyelitis Optica (nmo) App 20200393462 - Lennon; Vanda A. ; et al.	2020-12-17
Materials And Methods For Evaluating And Treating Cancer App 20200041505 - Pittock; Sean J. ; et al.	2020-02-06
Materials And Methods For Evaluating And Treating Neuromyelitis Optica (nmo) App 20190242892 - Lennon; Vanda A. ; et al.	2019-08-08
Materials And Methods For Evaluating And Treating Neuromyelitis Optica (nmo) App 20180246093 - Lennon; Vanda A. ; et al.	2018-08-30
Methods for treating neuromyelitis optica (NMO) by administration of eculizumab to an individual that is aquaporin-4 (AQP4)-IgG autoantibody positive Grant 9,891,219 - Lennon , et al. February 13, 2	2018-02-13
Materials And Methods For Evaluating And Treating Neuromyelitis Optica (nmo) App 20150104813 - Lennon; Vanda A. ; et al.	2015-04-16
Peripherin-specific Autoantibodies As A Marker For Neurological And Endocrinological Disease App 20140377883 - Lennon; Vanda A. ; et al.	2014-12-25
Neuromyelitis optica autoantibodies as a marker for neoplasia Grant 8,889,102 - Lennon , et al. November 18, 2	2014-11-18
Methods And Compositions For Detecting The Presence Of One Or More Autoantibodies App 20140315225 - Lennon; Vanda A. ; et al.	2014-10-23
Materials And Methods For Evaluating And Treating Neuromyelitis Optica (nmo) App 20140030262 - Lennon; Vanda A. ; et al.	2014-01-30
Peripherin-specific Autoantibodies As A Marker For Neurological And Endocrinological Disease App 20130023484 - Lennon; Vanda A. ; et al.	2013-01-24
Neuromyelitis Optica Autoantibodies As A Marker For Neoplasia App 20100226860 - Lennon; Vanda A. ; et al.	2010-09-09
Materials And Methods For Evaluating And Treating Neuromyelitis Optica (nmo) App 20100092478 - Lennon; Vanda A. ; et al.	2010-04-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.